The Covid-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we and our colleagues published in the journal Nature. While developing mRNA vaccines for patients with brain tumors in 2016, our team, led…
In the world of cancer treatment, time matters, not just in diagnosis, but in every hospital visit. Now, for many living with cancer, a new development brings relief, hope, and a lot more comfort. The NHS has introduced a cancer injection called nivolumab, which promises to transform how patients receive immunotherapy. And England is the…
A decade ago, treating cancer with personalised mRNA vaccines seemed like a US$1 million gamble per patient, a therapy reserved for the ultra-rich. But Chinese biotech start-ups are aiming to change that – by designing cancer therapy for a fraction of the cost and also taking on Western pharmaceutical giants in the process. Beijing-based Likang…
A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it one step closer to offering patients an alternative to antiretroviral therapy, and eventually a functional cure for the virus that causes Aids. Developed by Immuno Cure, based in Hong Kong Science Park, ICVAX demonstrated “exceptional…